Former Timberland & Sealy CEO Joins New Health Information Website RateADrug.com

MIAMI, April 29 /PRNewswire/ -- RateADrug.com (http://www.RateADrug.com), a new community-driven medical information website, today announced that noted business leader Carl Singer has joined its board of directors as non-executive Chairman.

Mr. Singer has served on 31 boards of directors and as CEO or President of leading companies including Sealy, BVD Company, Scripto, Microdyne, Renfield, Viragen and Timberland Industries. He is currently CEO and Chairman of Fundamental Asset Management, and a director of YourFreeLegalForms.com and FastDue.com.

"In addition to running some of America's most successful consumer companies, Carl Singer brings to RateADrug unique management experience in biotechnology clinical trials and in drug safety, efficacy and regulatory issues. We look forward to his hands-on participation," said RateADrug President Mark Deuitch.

Mr. Singer has served as a Board of Trustee member at Emory University in Atlanta, Georgia and is an active member of the Friends for Life at the University of Miami and the Renaissance Group of Dartmouth-Hitchcock Medical Center in New Hampshire. He has been recognized for his philanthropy by the Center for Medical Education at the University of Miami. He has been awarded the honorary degree of Doctor of Commerce by the Huizenga School of Business and Entrepreneurship at Nova Southeastern University in Ft. Lauderdale, FL.

Mr. Singer will assist RateADrug in establishing an alternative and more interactive class of patient-generated health information to complement traditional sources of health data such as FDA, NIH, and Mayo Clinic research and pharmaceutical warning labels disclosures.

About RateADrug.com:

RateADrug.com provides an online, community-based rating system that allows users to share information about possible side effects and benefits they experience from prescription drugs, medical procedures and nutritional supplements. The site uses anecdotal reports from highly diversified user groups to add to data from clinical trials and FDA disclosures. Users can evaluate and share their experiences about a broad range of medical treatments, alternative therapies and prescription drugs by participating in RateADrug's ongoing surveys.

RateADrug is currently conducting specific large-group studies for the following classes of drugs: cholesterol-lowering statin drugs Lipitor, Lescol, Mevacor, Pravachol, and Zocar; anti-depressants Lexapro, Prozac, Effexor, Paxil, Zoloft, and Pristiq, and insomnia treatments Ambien, Lunesta, Sonata, Rozerem, and Benzodiazepines. Users can currently review or submit ratings on over one thousand different medications at http://www.RateADrug.com.

SOURCE RateADrug.com

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.